logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
13/05/2025
Guggenheim: Reiterates rating on Kymera Therapeutics (KYMR.US) from Buy to Buy, target price adjusted from $52.00 to $52.00.
Latest
5 m ago
Bank of England board member Taylor: The Bank of England's core predictions on the global trade situation are "quite moderate."
8 m ago
Bank of England Governor Taylor: We still have a long way to go to reach the neutral interest rate level.
10 m ago
Bank of England committee member Taylor: If you wait for every piece of data to confirm the decline in inflation, you will fall behind the situation.
10 m ago
The US Treasury Department imposes new round of sanctions related to Iran.
11 m ago
Bank of England commissioner Taylor: The continued weakening of business confidence in the UK is still evident in retail sales and purchasing manager index surveys. Currently, the market is filled with caution and concern, and the impact of tariffs has exceeded market expectations. Although there are signs of a pause, we do not know what direction things will take next.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.